Bharat Biotech's partner Ocugen seeks approval for Covaxin in Canada

The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly 25,800 adults

Comments

Popular posts from this blog

Congress groomed me not to sit at home: Shivakumar

Infosys lays off hundreds after failing internal assessments in Mysuru

Greater Bengaluru Committee proposes seven municipal corporations